A biotech company out to corner a new market in the diabetes and weight loss space has recorded its second, and so far largest, raise yet.
The company’s new approach, through a simple blood test, will ultimately accelerate the means of providing effective treatments to the right people at the right time.
Mr. Claiborne brings extensive experience in leadership roles with clinical and commercial stage, publicly traded biopharmaceutical companies.
Dr. Wamhoff is a founder of HemoShear where he co-developed HemoShear’s REVEAL-Tx™ drug discovery platform.
For more than 15 years, the Focused Ultrasound Foundation has been dedicated to advancing the development and adoption of focused ultrasound.
Adial Pharmaceuticals Announces Topline Results For Onward™ Phase 3 Trial for AD04 in Patients with Alcohol Use Disorder
Company plans to submit ONWARD results to both European and U.S. regulatory agencies.
The quest for funding can be a stressful experience for entrepreneurs hoping to launch a biotech startup. The need for seed funding is essential but where are the best sources?
AMPEL BioSolutions' Precision Medicine Breakthrough Predicts Drug Options with RNA Analytics & Machine Learning
The technology is being utilized to launch a portfolio of 10+ clinical tests over the next five years to provide decision support for diseases affecting more than 50 million Americans.